Bayer

Bayer is an enterprise with core competencies in the life science fields of healthcare and nutrition. They design their products and services to help people and the planet thrive by supporting efforts to address unprecedented challenges. Their businesses include pharmaceuticals, consumer health, and crop science. They focus on developing and commercializing products and solutions based on scientific knowledge.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$12M €3B

Bayer has raised a total of $12M €3B in funding over 2 rounds. Their latest funding was raised on Nov 8, 2022 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 8, 2022	Grant	$12M	1	Bill & Melinda Gates Foundation	—	Detail
Apr 17, 2018	Post-IPO Equity	€3B	1	Temasek Holdings	—	Detail
Oct 2, 2009	IPO	—	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

30

13

Bayer has made 30 investments. Their most recent investment was on Jun 20, 2022, when OME Health raised 0.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Jun 20, 2022 OME Health	Seed	—	Analytics	—
Mar 1, 2021 Grão Direto	Series Unknown	R$18M	Agriculture	—
Nov 17, 2020 Elly	Series Unknown	—	Health Care	—
Aug 24, 2020 OneDrop	Series C	$34.70M	Apps	Yes
Feb 27, 2020 Oerth Bio	Corporate Round	$55M	Biotechnology	—

Investors

Number of Lead Investors

Number of Investors

2

Bayer is funded by 2 investors. Bill & Melinda Gates Foundation and Temasek Holdings are the most recent investors.

Investor Name	Lead Investor	Funding Round
Bill & Melinda Gates Foundation	Yes	Grant
Temasek Holdings	Yes	Post-IPO Equity

Employee Profiles

Number of Employee Profiles

61

Bayer has 61 current employee profiles, including Employee Kate Humphrey

Employee

Executive

Executive

Executive

Employee

Exits

Bayer has had 2 exits. Bayer most notable exits include Covercress , BlueRock Therapeutics

Date	Company Name	Exit Type	Industry
Aug 1, 2022	Covercress	M&A	Animal Feed	Detail
Aug 8, 2019	BlueRock Therapeutics	M&A	Biopharma	Detail

Acquisition

Bayer has acquired 16 organizations. Their most recent acquisition was Zeptosens on Mar 9, 2005. They acquired Zeptosens for 0.

Date Company Name	Industry	Acquisition Type	Price
Mar 9, 2005 Zeptosens	Biotechnology	—	—	Detail
Feb 13, 2006 Icon Genetics	Agriculture	—	—	Detail
Mar 11, 2010 Artificial Muscle Inc.	Electronics	acquisition	—	Detail
Jul 1, 2012 AgraQuest	Agriculture	acquisition	$ 425M	Detail
Dec 19, 2013 Algeta	Biotechnology	acquisition	$ 2.90B	Detail